Home » Abbott’s New Use for Top Drug Humira Delayed by U.S.
Abbott’s New Use for Top Drug Humira Delayed by U.S.
Abbott’s bid to expand use of its best-selling arthritis treatment Humira to ulcerative colitis patients is being delayed by U.S. regulators.
Businessweek
Businessweek
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May